Showing 6,261 - 6,280 results of 27,187 for search '(( 5 ((teer decrease) OR (nn decrease)) ) OR ( 50 ((a decrease) OR (mean decrease)) ))', query time: 0.82s Refine Results
  1. 6261

    Data set. by Muriel Aldunate (22411177)

    Published 2025
    “…LA decreased HIV-1 virion-associated RNA levels by ∼50% compared to untreated virus (p < 0.001), acetic acid or HCl acidified media. …”
  2. 6262

    Spatial expression pattern of proBcMF26a: GUS-GFP. by Meiling Lyu (767333)

    Published 2015
    “…<p>(A–L) Histochemical GUS assays of the T<sub>2</sub><i>Arabidopsis</i> transformed with pBGWFS7.0–proBcMF26a: GUS-GFP vector. …”
  3. 6263

    Data Sheet 7_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  4. 6264

    Data Sheet 6_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  5. 6265

    Data Sheet 1_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  6. 6266

    Data Sheet 3_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  7. 6267

    Data Sheet 8_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  8. 6268

    Data Sheet 4_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  9. 6269

    Data Sheet 5_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  10. 6270

    Data Sheet 2_Phosphodiesterase 7: a potential novel therapeutic target in ovarian cancer.pdf by Nayara Gusmão Tessarollo (18228556)

    Published 2025
    “…</p>Results and discussion<p>MTT assays revealed that while BRL 50481 reduced metabolic cellular viability (MCV) in A2780 (IC50 = 200 μM), its combination with PTX decreased MCV in both lines, reducing PTX IC50 by 103- and 625-fold in A2780 and OVCAR3, respectively. …”
  11. 6271
  12. 6272
  13. 6273
  14. 6274
  15. 6275
  16. 6276
  17. 6277

    Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir by Ana I. de Ávila (3226722)

    Published 2016
    “…Infectivity decreased significantly in the presence of concentrations of T-705 which are 2- to 8-fold lower than its cytotoxic concentration 50 (CC<sub>50</sub>). …”
  18. 6278

    Fluorinated Carbon Nanotube Superamphiphobic Coating for High-Efficiency and Long-Lasting Underwater Antibiofouling Surfaces by Dongjiu Zhang (11221397)

    Published 2021
    “…In addition, the coating possessed excellent wear resistance, the CAs of BSA and BS solution just decreased slightly (higher than 158°), and the sliding angles increased slightly (lower than 4°) after 50 tape abrasion cycles. …”
  19. 6279

    Fluorinated Carbon Nanotube Superamphiphobic Coating for High-Efficiency and Long-Lasting Underwater Antibiofouling Surfaces by Dongjiu Zhang (11221397)

    Published 2021
    “…In addition, the coating possessed excellent wear resistance, the CAs of BSA and BS solution just decreased slightly (higher than 158°), and the sliding angles increased slightly (lower than 4°) after 50 tape abrasion cycles. …”
  20. 6280

    Fluorinated Carbon Nanotube Superamphiphobic Coating for High-Efficiency and Long-Lasting Underwater Antibiofouling Surfaces by Dongjiu Zhang (11221397)

    Published 2021
    “…In addition, the coating possessed excellent wear resistance, the CAs of BSA and BS solution just decreased slightly (higher than 158°), and the sliding angles increased slightly (lower than 4°) after 50 tape abrasion cycles. …”